We want to empower people to live life to the fullest.
Read more about Orion’s commitment to patientsStock exchange releases
- 12/19/2024 CORRECTION: Change in Orion Group Executive Management Board as of 1 June 2025 – Mikko Kemppainen appointed General Counsel
- 12/19/2024 Change in Orion Group Executive Management Board as of 1 June 2025 – Mikko Kemppainen appointed General Counsel
- 12/12/2024 Penalty payment to a member of Orion’s Board of Directors for delay in notifying managers’ transaction
- 11/27/2024 142,701 Orion Corporation A shares converted into B shares
Press releases
- 1/7/2025 Orion’s collaboration partner Bayer submits application in China for third indication of darolutamide
- 12/30/2024 Orion and Marinus terminate agreement for ganaxolone in Europe
- 12/18/2024 Orion and Abilita Therapeutics announce research collaboration and option to license agreement to develop innovative antibody therapeutics
- 11/22/2024 Orion Research Foundation grants EUR 1,109,000 for research in 2025